Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

BioCardia, Inc. - Common Stock (NQ:BCDA)

2.240 +0.140 (+6.67%)
Streaming Delayed Price Updated: 12:27 PM EDT, Jul 8, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about BioCardia, Inc. - Common Stock

< Previous 1 2 3 4 5 Next >
Earnings Scheduled For May 14, 2025
Via Benzinga
Earnings Scheduled For November 13, 2024
Via Benzinga
12 Health Care Stocks Moving In Friday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
12 Health Care Stocks Moving In Tuesday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Peering Into BioCardia's Recent Short Interest
Via Benzinga
Why BioCardia (BCDA) Stock Is Falling Today
BioCardia shares are trading lower by 12% during Friday's session. The company announced the pricing of an upsized public offering. 
Via Benzinga
BCDA Stock Earnings: BioCardia Reported Results for Q2 2024
BioCardia just reported results for the second quarter of 2024. 
Via InvestorPlace
Earnings Scheduled For March 26, 2025
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why MongoDB Shares Are Trading Higher By Around 15%; Here Are 20 Stocks Moving Premarket
Via Benzinga
BCDA Stock Earnings: BioCardia Reported Results for Q1 2024
BioCardia just reported results for the first quarter of 2024. 
Via InvestorPlace
BioCardia: Q4 Earnings Insights
Via Benzinga
Crude Oil Moves Higher; Dollar General Earnings Miss Estimates
Via Benzinga
Topics Earnings
Nasdaq Surges Over 1%; Best Buy Posts Upbeat Earnings
Via Benzinga
Dow Jumps Over 100 Points; Nvidia Earnings Top Views
Via Benzinga
Topics Stocks
Why BioCardia (BCDA) Stock Is Up 95% Today
BioCardia shares are trading higher by 95% during Thursday's session. The FDA cleared the company to market its Morph DNA Steerable Introducer product family. 
Via Benzinga
Why Affirm Shares Are Trading Higher By Around 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Skye Bioscience Shares Are Trading Lower By 19%? Here Are Other Stocks Moving In Monday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Monday's Pre-Market Session
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Monday
Pre-market stock movers are worth diving into on Monday and we have all of the latest news worth knowing about this morning! 
Via InvestorPlace
Why KKR Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga
What's Going with BioCardia Stock Friday?
On Friday before the market open, BioCardia announced it received approval from the United States Patent Office for its application entitled, "Radial and Transendocardial Delivery Catheter." 
Via Benzinga
Topics Intellectual Property
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
BCDA Stock Earnings: BioCardia Misses EPS, Misses Revenue for Q2 2023
BCDA stock results show that BioCardia missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2023. 
Via InvestorPlace
Expensify And 2 Other Stocks Under $2 Insiders Are Buying
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
BCDA Stock Earnings: BioCardia Beats EPS, Misses Revenue for Q4 2023
BCDA stock results show that BioCardia beat analyst estimates for earnings per share but missed on revenue for the fourth quarter of 2023. 
Via InvestorPlace
Earnings Scheduled For March 27, 2024
Companies Reporting Before The Bell • Local Bounti (NYSE:LOCL) is projected to report quarterly loss at $2.41 per share on revenue of $8.70 million. 
Via Benzinga
< Previous 1 2 3 4 5 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.